Immunosenescence (the aging immune system)

The immune system ages on its own schedule, and badly: the thymus that trains new immune cells shrinks to almost nothing by midlife, the surveillance cells that hunt cancers and infections lose their edge, and the cellular repertoire fills with worn-out cells that no longer fight but still leak inflammation. This decline is one of the quieter engines of aging — it overlaps heavily with inflammaging and helps let senescent "zombie" cells pile up. The encouraging part is that the levers that slow it are the familiar ones: regular vigorous exercise above all, then sensible energy balance and sleep. The molecular shortcuts in the headlines — IL-15 drugs and "exercise-in-a-pill" supplements — are either dangerous, unproven, or both.

Immunosenescence is the age-related remodelling and decline of the immune system, and it sits close to the integrative tier of the twelve hallmarks of aging — it is less a single root cause than a system-wide failure that both results from upstream damage and then accelerates it.^[1] Much of its story can be told through one cytokine — interleukin-15 (IL-15) — which turns out to be a central regulator of the immune cells that age worst, and a useful lens on why the body's defences fade and what, realistically, keeps them sharp.

What breaks down

The most consequential single event is thymic involution. The thymus — the organ that schools fresh T-cells — begins shrinking in early adulthood and is largely replaced by fat by the time most people reach their fifties. As its output of new naive T-cells dries up, the immune system is forced to lean on an ever-narrower pool of existing memory cells, leaving it slower to recognise threats it hasn't seen before — which is part of why vaccines work less well and new infections hit harder with age.^[2]

At the same time the surviving T-cells degrade in a characteristic way. The defining marker is loss of CD28, a molecule T-cells need for proper activation; as cells lose it they take on senescence markers such as CD57 and KLRG1, divide poorly, and — like the senescent cells described under cellular senescence — stop doing useful work while pumping out inflammatory cytokines.^[3] Meanwhile the innate side weakens too: the cytotoxic power of natural killer (NK) cells, the body's first responders against virus-infected and pre-cancerous cells, falls with age, and low NK activity in older people tracks with higher infection and cancer risk.^[4] The net effect is a system that is simultaneously less protective and more inflammatory — the immune contribution to inflammaging.

IL-15: the cytokine that ties immune aging together

If one molecule sits at the centre of immune aging, it is IL-15. It is the principal survival and growth signal for exactly the cells that fare worst with age — memory CD8⁺ T-cells and NK cells.^[5]

What makes IL-15 unusual is how it is delivered. Rather than being released freely into the blood — which would be dangerous for so potent an inflammatory signal — it is mostly handed over cell-to-cell: a producing cell holds IL-15 on its surface and presents it directly to a neighbouring lymphocyte, a mechanism called trans-presentation that keeps the signal local and tightly controlled.^[6] When that signal lands, it switches on the JAK/STAT5 pathway and raises the anti-death protein Bcl-2, which is what keeps memory T-cells and NK cells alive.^[7]

IL-15 also pushes directly against T-cell aging. It sustains the activity of telomerase, the enzyme that maintains the protective caps on chromosomes whose erosion is covered under telomere attrition; in laboratory memory CD8⁺ T-cells, IL-15 minimises telomere loss across repeated divisions and helps preserve their replicative lifespan.^[8] In tumour-specific memory T-cells it can even turn down the cell-cycle brakes (p16, p21, p53) that enforce senescence, restoring their ability to divide.^[9] The catch — and it is the central catch of the whole topic — is that these are effects of appropriate IL-15 signalling. Too much, for too long, does the opposite, as the section below on the pulsatile principle explains.

NK cells and the clearing of senescent cells

One of the most important jobs of a youthful immune system is senolysis — physically finding and killing senescent cells before they accumulate. NK cells and cytotoxic T-cells are the main agents of this clean-up, and it is largely IL-15 that keeps them fit to do it.^[10] When NK function fades with age, senescent cells linger and their SASP spreads — the immune-surveillance failure that the cellular senescence article describes from the senescent cell's side.

Senescent cells do not go quietly. They actively evade immune clearance using tactics that look strikingly like a tumour's. They secrete the immunosuppressive signal TGF-β, which blunts NK cells' activating receptors, and they shed decoy molecules (soluble NKG2D ligands such as MICA and MICB) that mop up and exhaust those receptors before the NK cell can make contact — effectively cloaking themselves.^[11] This is part of why simply "boosting" immunity is harder than it sounds: the targets fight back.

The centenarian paradox

The cleanest natural experiment in immune aging comes from people who have aged exceptionally well. Centenarians carry higher circulating IL-15 than either healthy young adults or typical elderly people.^[12] On its face that is a paradox: IL-15 is pro-inflammatory, so high levels ought to mean runaway inflammaging. Instead, centenarians' T-cells show telomerase activity and proliferative capacity closer to people decades younger.^[13]

The resolution is that they run the opposing brake at the same time. Where ordinary aging tilts the balance toward inflammatory Th17 cells, centenarians keep a lower Th17-to-regulatory-T-cell ratio and flood the system with anti-inflammatory mediators (TGF-β, IL-10).^[14]^[15] The lesson is the same one that runs through the inflammaging article: exceptional immune aging is not about suppressing the immune system, but about pairing aggressive surveillance with an equally strong off-switch — precision and resolution, not blanket quiet.

The pulsatile principle, and why exercise is the lever

The single most useful idea in this area is that IL-15 has to come in pulses. Brief, transient spikes rejuvenate immune cells; chronic, unremitting elevation exhausts them. When human NK cells are bathed continuously in IL-15, they initially ramp up but then suffer a metabolic collapse — fatty-acid oxidation falls, spare respiratory capacity disappears, and the cells lose their ability to kill.^[16] Overdriving the PI3K–mTOR pathway is the culprit: dialling the signal back down, or simply giving the cells a break between exposures, prevents the exhaustion.^[17] This is why chronically elevated IL-15 — from obesity, persistent viral infection, or continuous drug dosing — is harmful, while episodic spikes are not.

The body's natural way of generating those spikes is muscular work. Skeletal muscle is an endocrine organ, and during contraction it releases IL-15 as a myokine under the control of the cellular energy sensor AMPK; mice engineered to lack muscle AMPK lose this exercise-driven IL-15 and show accelerated skin aging — thinner dermis, less collagen — which low-dose IL-15 partly reverses.^[18] In humans, both high-intensity interval training and resistance training reliably spike circulating IL-15 immediately after a session across ages and sexes, while resting levels stay largely unchanged with long-term training.^[19] That is exactly the pulsatile pattern the biology calls for — and it dovetails with the muscle-derived "IL-6 paradox" already described under chronic inflammation and the broader case for resistance training.

What actually helps — the lifestyle levers

As with every hallmark, the evidence is strongest for the unglamorous interventions, and they work by keeping the whole body in good metabolic and inflammatory order rather than by targeting IL-15 directly.

Exercise, especially intense and varied. This is the best-supported lever, and the mechanism is clean: HIIT and heavy resistance training produce the transient IL-15 spikes that prime NK and memory T-cells without the chronic elevation that exhausts them.^[20] Beyond the immune signal, muscle-derived IL-15 improves the muscle's own oxidative metabolism and glucose uptake.^[21]

Sensible energy balance, not extreme leanness. Moderate caloric restriction reverses a specific, harmful pattern: in aging fat tissue, IL-15 signalling and its receptor become chronically over-expressed, which (alongside TNF-α) damages insulin signalling — and lifelong moderate restriction prevents that, preserving insulin sensitivity into old age.^[22] The framing is the same as in the chronic inflammation article: much of the benefit rides on fat loss and dietary quality, not on any schedule trick. One caveat-laden finding is that very low carbohydrate or energy availability can blunt the post-exercise myokine response in athletes — a single-cohort observation, not a licence to carb-load.^[23]

Sleep. Adequate, regular sleep preserves the anti-inflammatory feedback that immune aging erodes, the same reasoning laid out for inflammaging; it is a genuine immune-maintenance input, not a recovery nicety.

The drug and supplement frontier

A great deal of money is chasing IL-15 pharmacologically, and the results are a useful illustration of why the pulsatile principle matters — none of this is established for healthy adults.

IL-15 superagonists (N-803, formerly ALT-803) are engineered to deliver a strong, long-lasting IL-15 signal, and in cancer trials — combined with checkpoint inhibitors or other agents — they have produced real responses.^[24] But the safety profile is exactly what the exhaustion biology predicts from sustained systemic IL-15: dose-limiting capillary-leak syndrome, hypertension, and a drop in platelets, with serious events in the sickest patients.^[25] These are cancer drugs with a difficult risk profile, not longevity tools; the broader class of unproven anti-aging drugs is covered under geroprotectors.
Engineered IL-15 cell therapies tether the cytokine to the surface of NK cells so its signal stays local, avoiding systemic leak — a promising idea in experimental cancer immunotherapy, but firmly confined to the lab.^[26]
Supplements marketed as "exercise mimetics" — beta-alanine, the plant compounds eugenol and octacosanol, and multi-ingredient mitochondrial cocktails — are reported to raise IL-15 or its downstream signalling, but the evidence is single small trials, cell-culture work, or animal studies, with no demonstration of immune or longevity benefit in healthy people.^[27]^[28]^[29] Treat them as research, not advice. The honest summary is that no supplement is a substitute for the muscular work that produces IL-15 the way the body intends.

It is also worth knowing that IL-15 is not benign when dysregulated upward: chronically high local IL-15 is a driver of autoimmune disease, most clearly in celiac disease, where gluten-triggered IL-15 in the gut lining breaks immune tolerance and destroys the intestinal surface.^[30] More is emphatically not better.

What this does and doesn't tell you

What it tells you: immune aging is real, measurable, and partly tractable. The thymus shrinks, NK and T-cell surveillance fades, and the immune system's failure to clear senescent cells feeds the same inflammaging that drives age-related disease. IL-15 is the thread that ties it together — and the organising principle it reveals, that immune cells are rejuvenated by pulses of signalling but exhausted by continuous elevation, explains both why exercise helps and why systemic IL-15 drugs are dangerous. The proven levers are the familiar ones: vigorous, varied exercise first, then sensible energy balance and sleep.

What it doesn't tell you: that any IL-15 drug or supplement is safe or beneficial for a healthy person — chronically raising IL-15 is actively harmful, and the centenarian data showing high IL-15 alongside exceptional longevity is observational, reflecting a whole finely-balanced immune phenotype rather than one molecule you can take. As everywhere in this field, the elegance of the mechanism runs well ahead of the proven interventions, and the proven interventions are the unglamorous ones.